Datamonitor: Commercial Insight - Cytotoxic Therapies on reports-research.com

Despite the advent of molecular targeted therapies, cytotoxic chemotherapy remains the cornerstone of cancer treatment and is used across nearly the entire spectrum of tumor types. A number of cytotoxic drugs are on the market, however only a few currently dominate in terms of revenues, with Taxotere (docetaxel; Sanofi-Aventis), Eloxatin (oxaliplatin; Sanofi-Aventis) and Gemzar (gemcitabine; Eli Lilly) the three leading cytotoxics in terms of sales in 2008, with 7MM annual sales of over $1 billion.

Despite undergoing patent expiry during the forecast period, Taxotere and Eloxatin and Dacogen (decitabine; Eisai/Johnson & Johnson) will remain in the top three cytotoxics in 2018, and generic entry will ensure continued market growth. The launch of several new brands will also mean the cytotoxics market is expected to see growth continuing out to 2018, at a CAGR of 3.1%.
However, the increasingly competitive nature of the market has raised significant barriers to entry and any new product will need to show superiority over the competition.

This Datamonitor report Commercial Insight - Cytotoxic Therapies analyzes the current and future potential of the cytotoxic therapies market. It includes sales forecasts to 2018 across the seven major pharmaceutical markets (7MM), taking into account the key events predicted to influence product revenues, such as the launch of new drugs, expansion of existing drugs into new indications and patent expiries.

This comprehensive report offers:

• An in-depth analysis of the current and future cytotoxic therapies market across the US, 5EU and Japan, plus a rest of world snapshot.

• Cytotoxic therapy sales forecasts for brands and generics from 2008 to 2018.

• An assessment of the leading cancer brands and drug classes, designed to help identify key success factors within this sector.

• An analysis of the strategies of several leading players in the cytotoxics market.



To purchase this Datamonitor report Commercial Insight: Cytotoxic Therapies please contact:

reports-research.com
c/o dynamic technologies GmbH

Manuel Bravo Sanchez (CEO)

info@reports-research.com

Datamonitor: More market data and market reports:
http://www.reports-research.com/studien/datamonitor-m-29.html

markt-studie.de, founded in 2002 has emerged as a leading online portal for market surveys and market research in German speaking areas. Four years later the English language portal reports-research.com was introduced due to the extraordinary success of the portal. Again one year later estudio-mercado.es - the Spanish spoken portal - was founded. The objective of the three portals is to competently and efficiently support consultants and decision makers in management, sales and marketing in the search for worldwide market research. Prospective buyers can look into more than 60,000 market surveys from more than 200 international publishers, current market data for more than 6,000 branches worldwide, 10,000 company profiles as well as a free-of-charge research and recommendation service for individual market research.

reports-research.com
c/o dynamic technologies GmbH
Siegburger Str. 233
50679 Köln
Germany

Manuel Bravo Sanchez (CEO)

info@reports-research.com

or
Tel ++49 (0)221 690 688 55
Fax ++49 (0)221 690 688 56

This release was published on openPR.